Moxifloxacin Disrupts and Attenuates Aβ42 Fibril and Oligomer Formation: Plausibly Repositioning an Antibiotic as Therapeutic against Alzheimer’s Disease-Reference-Cited by-同舟云学术

Moxifloxacin Disrupts and Attenuates Aβ42 Fibril and Oligomer Formation: Plausibly Repositioning an Antibiotic as Therapeutic against Alzheimer’s Disease

Published:2022-08-05 Issue:16 Volume:13 Page:2529-2539
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Khan Asra Nasir¹,Nabi Faisal¹^ORCID,Ajmal Mohammad Rehan²,Ali Syed Moasfar¹,Almutairi Fahad M.²,Alalawy Adel I.²,Khan Rizwan Hasan¹^ORCID

Affiliation:

1. Interdisciplinary Biotechnology Unit, AMU, Aligarh 202002, India

2. Physical Biochemistry Research Laboratory, Biochemistry Department, Faculty of Science, University of Tabuk, Tabuk 71491, Saudi Arabia

Funder

Council of Scientific and Industrial Research

University Grants Commission

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.2c00371

Reference80 articles.

1. Amyloid Accumulation and Pathogensis of Alzheimer’s Disease: Significance of Monomeric, Oligomeric and Fibrillar Aβ

2. Amyloid-beta peptide and tau protein crosstalk in Alzheimer’s disease

3. Parkinson disease

4. Huntington's disease: a clinical review

5. Proteostasis of Islet Amyloid Polypeptide: A Molecular Perspective of Risk Factors and Protective Strategies for Type II Diabetes

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Doxorubicin as a Drug Repurposing for Disruption of α-Chymotrypsinogen-A Aggregates;The Protein Journal;2024-07-16

2. Natural compound plumbagin based inhibition of hIAPP revealed by Markov state models based on MD data along with experimental validations;Proteins: Structure, Function, and Bioinformatics;2024-03-18

3. An Insight into the Protein Aggregation in Alzheimer’s Disease and its Inhibition;Protein & Peptide Letters;2023-11

4. Perturbations in Microbiota Composition as a Novel Mediator in Neuropsychiatric, Neurological and Mental Disorders: Preventive and Therapeutic Complementary Therapies to Balance the Change;Current Alzheimer Research;2023-04

5. Protein misfolding and related human diseases: A comprehensive review of toxicity, proteins involved, and current therapeutic strategies;International Journal of Biological Macromolecules;2022-12